BIOMAT Database Logo BIOMAT Database Logo

Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines. 2014

Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Department of Chemistry, Siedlce University of Natural Sciences and Humanities, ul. 3 Maja 54, Siedlce 08-110, Poland.

A new series of sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazine has been synthesized and characterized. Their anticancer activity was tested in vitro against multiple human cancer cell lines and were found to have dose-dependent antiproliferative effects. Furthermore, some of the new compounds inhibited the Abl protein kinase with low micromolar IC50 values and exhibited selective activity against the Bcr-Abl positive K562 and BV173 cell lines, providing starting points for the further development of this new kinase inhibitor scaffold.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
January 2018, Medicinal chemistry (Shariqah (United Arab Emirates)),
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity.
December 2014, Bioorganic & medicinal chemistry,
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis, Structural Characterization, and Biological Activity of New Pyrazolo[4,3-e][1,2,4]triazine Acyclonucleosides.
January 2020, Molecules (Basel, Switzerland),
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis and antimicrobial activity of some new pyrazole, fused pyrazolo[3,4-d]-pyrimidine and pyrazolo[4,3-e][1,2,4]-triazolo[1,5-c]pyrimidine derivatives.
July 2008, Molecules (Basel, Switzerland),
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-e][1,2,4]triazine Derivatives.
August 2020, Molecules (Basel, Switzerland),
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
The activity of pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures.
December 2024, Journal of enzyme inhibition and medicinal chemistry,
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions.
November 2008, Bioorganic & medicinal chemistry,
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Pyrazolo[4,3-e][1,2,4]triazines: purine analogues with electronic absorption in the visible region.
October 2005, Molecules (Basel, Switzerland),
Mariusz Mojzych, and Veronika Šubertová, and Anna Bielawska, and Krzysztof Bielawski, and Václav Bazgier, and Karel Berka, and Tomáš Gucký, and Emilia Fornal, and Vladimír Kryštof
Cyclocondensation reaction of heterocyclic carbonyl compounds. Part XIII: synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines.
February 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!